FISCHETTI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 9.183
EU - Europa 4.104
AS - Asia 4.081
SA - Sud America 484
AF - Africa 149
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.017
Nazione #
US - Stati Uniti d'America 9.060
SG - Singapore 1.566
CN - Cina 918
IT - Italia 831
PL - Polonia 621
SE - Svezia 601
UA - Ucraina 541
HK - Hong Kong 456
BR - Brasile 377
VN - Vietnam 334
KR - Corea 291
FI - Finlandia 233
FR - Francia 225
GB - Regno Unito 207
DE - Germania 206
TR - Turchia 179
NL - Olanda 146
RU - Federazione Russa 145
IE - Irlanda 94
BG - Bulgaria 88
MA - Marocco 73
IN - India 71
BD - Bangladesh 65
CA - Canada 52
MX - Messico 47
AR - Argentina 40
ES - Italia 35
CH - Svizzera 32
ZA - Sudafrica 32
JP - Giappone 26
BE - Belgio 23
EC - Ecuador 20
IQ - Iraq 19
SA - Arabia Saudita 19
AT - Austria 18
ID - Indonesia 18
CZ - Repubblica Ceca 16
UZ - Uzbekistan 12
AZ - Azerbaigian 11
IL - Israele 11
PK - Pakistan 11
PH - Filippine 10
RO - Romania 10
VE - Venezuela 10
SN - Senegal 9
CO - Colombia 8
MY - Malesia 8
PE - Perù 8
TN - Tunisia 8
EG - Egitto 7
IR - Iran 7
AU - Australia 6
UY - Uruguay 6
CR - Costa Rica 5
EU - Europa 5
JO - Giordania 5
KG - Kirghizistan 5
NP - Nepal 5
PT - Portogallo 5
TH - Thailandia 5
CL - Cile 4
GR - Grecia 4
LK - Sri Lanka 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BS - Bahamas 3
DZ - Algeria 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SR - Suriname 3
TW - Taiwan 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 17.998
Città #
Woodbridge 1.052
Singapore 917
Ashburn 893
Ann Arbor 768
Fairfield 691
Houston 632
San Jose 575
Chandler 548
Warsaw 517
Jacksonville 465
Hong Kong 451
Wilmington 337
Seattle 300
Seoul 290
Beijing 224
Cambridge 209
Hefei 195
Boardman 179
Princeton 168
Izmir 149
Chicago 124
Columbus 117
Dallas 114
Trieste 114
Los Angeles 109
Ho Chi Minh City 96
Lauterbourg 95
Dublin 92
Zgierz 91
Sofia 86
Milan 85
Hanoi 81
Moscow 79
Casablanca 64
New York 62
Buffalo 57
The Dalles 57
London 56
Santa Clara 56
Helsinki 52
Dearborn 50
San Diego 48
Düsseldorf 46
Frankfurt am Main 44
Rome 43
Falls Church 39
Munich 39
São Paulo 34
Council Bluffs 29
Shanghai 29
North Bergen 28
Bern 26
Denver 24
Orem 24
Washington 24
Brussels 23
Redondo Beach 23
Tokyo 23
Brooklyn 21
Phoenix 21
Atlanta 20
Turku 20
Jinan 19
Manchester 19
Des Moines 18
Johannesburg 18
Montreal 18
Haiphong 17
Miano 17
Norwalk 17
Sacile 16
Memphis 15
Da Nang 14
Florence 14
Fremont 14
Guangzhou 14
Mexico City 14
Mumbai 14
Rio de Janeiro 14
Poplar 13
Segrate 13
Amsterdam 12
Nanjing 12
Nuremberg 12
Paris 12
Tashkent 12
Chennai 11
Hangzhou 11
Vienna 11
Belo Horizonte 10
Bexley 10
Auburn Hills 9
Baku 9
Brescia 9
Nanchang 9
Palermo 9
Verona 9
Baghdad 8
Biên Hòa 8
Bologna 8
Totale 12.414
Nome #
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients 482
A new ultrasonographic instrument for measuring vessel wall shear stress. 479
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 414
Hypertrophic osteoarthropathy mimicking a reactive arthritis: A case report and review of the literature 389
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 316
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 308
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 273
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 261
Systemic and regional haemodynamic effects of aortofemoral angiography 254
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 254
Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis [Iperpiressia ed eritema cutaneo in una paziente trattata con sulfasalazina per artrite psoriasica] 241
Antihypertensive activity of arylidenaminoguanidine derivatives. 239
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 236
Baroreceptor-heart rate reflex sensitivity enhancement after urinary bladder distention in essential hypertensives 232
Acute effects of intravenous infusions of alcohol on baroreceptor sensitivity in essential hypertension. 229
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 227
Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients. 224
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]. 219
Ace inhibition in renal disease: risks and benefits. 219
Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The "EPIDAURO registry" 214
Reduction of blood pressure in obese hyperinsulinaemic hypertensive patients during somatostatin infusion 209
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 208
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis. 206
An ultrasonographic method to measure the sensitivity of the baroreflex in clinical practice: application to pharmacological studies. 204
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 200
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 199
Anticorpi anti-Beta2 Glicoproteina 1: non solo marker diagnostico ma anche mediatore patogenetico della sindrome da anticorpi anti-fosfolipidi 195
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 194
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. 194
[Adenylate cyclase activity--after stimulation of beta-receptors with isoproterenol--in relation to the presence or absence of monocytes in a population of mononucleated cells]. 194
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 193
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 193
[Cardio-regulatory reflexes in patients with alcoholic liver cirrhosis]. 190
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 185
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 184
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 182
[Distensibility of large arteries after chronic treatment with nicardipine SR in aged hypertensive patients]. 182
Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension. 181
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 181
Complement-endothelial cell interactions: pathophysiological implications. 177
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 176
Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro. 176
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A. 175
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 174
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 174
Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis. 170
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 170
GENDER AND FIBROMYALGIA SEVERITY: REAL LIFE DATA FROM THE ITALIAN REGISTRY 169
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 169
Regional hemodynamic effects of slow-release nicardipine in elderly patients with hypertension: evaluation by a new ultrasound technique. 168
Relationship between mechanical properties of the carotid artery wall and baroreflex function in acutely treated hypertensive patients 167
Arterial compliance and baroreceptor sensitivity after chronic treatment with indapamide. 167
Association between fibromyalgia and chronic autoimmune thyroiditis. Retrospective observational data from a monocentric endocrinologist-rheumatologist collaborative analysis 164
[Empty sella syndrome]. 164
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 163
Carotid artery wall shear stress after LDL-apheresis in familial hypercholesterolemia. 163
”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco. 161
[Clinical case. Primary or secondary hypertension?]. 160
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. 157
Regional and systemic haemodynamic response to aortography in hypertensives. 155
Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions 153
Effects of amlodipine on renal hemodynamics. 151
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 150
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 150
Feto-maternal immune interaction at the placental level 149
Effects of rilmenidine and hydrochlorothiazide on human platelet α2-adrenoceptors 149
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study 147
Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. 147
POS1435 CLINICAL CHARACTERIZATION AND PREDICTIVE FACTORS FOR PROGRESSION IN A COHORT OF ILD PATIENTS WITH FEATURES OF AUTOIMMUNITY: ARE IPAF CRITERIA SUFFICIENT? 144
Conflicting results on peripheral adrenoceptor function in hypotension of hemodialyzed patients. 138
Pathophysiological consequences of complement-endothelial cell interaction 135
Effects of Rilmenidine and Hydrochlorothiazide On Human Platelet Alpha(2)-adrenoceptors 132
Clinical case:Bartter's syndrome 132
Reflex control of the heart rate in alcoholic liver cirrhosis 131
Inhibition of trophoblast adhesion to endothelial cells by the sera of women with recurrent spontaneous abortions. 131
Regulation of platelet alpha2 adrenergic receptors in a population of patients with essential arterial hypertension and in normotensive subjects 131
Empy sella syndrome 129
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. 129
Measurement of the efficacy of antihypertensive drugs in experimental animals. 129
null 128
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 126
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 123
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 122
null 121
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSIS 115
FRI0641-HPR INTERSTITIAL LUNG DISEASE AS INITIAL MANIFESTATION OF SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES IN A MONOCENTRIC COHORT: THE IMPORTANCE OF A MULTIDISCIPLINARY APPROACH 114
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients 113
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study 108
Ruolo del sistema del Complemento nello sviluppo del danno infiammatorio articolare 101
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 98
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 96
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 96
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 93
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 91
The complement system: Novel roles in health and disease 91
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 91
Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDs 88
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 85
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 82
La sindrome trombofilica in corso di LES 82
Totale 17.724
Categoria #
all - tutte 54.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.040 35 84 43 102 37 108 46 27 117 123 46 272
2022/20231.554 144 207 148 189 117 316 6 125 199 21 64 18
2023/20241.041 68 68 101 45 107 117 159 170 31 27 53 95
2024/20252.270 64 32 71 221 327 262 135 122 317 298 204 217
2025/20265.626 479 284 384 566 519 509 799 150 703 905 186 142
2026/202727 27 0 0 0 0 0 0 0 0 0 0 0
Totale 18.243